2009
DOI: 10.1007/s00432-009-0704-3
|View full text |Cite
|
Sign up to set email alerts
|

Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription

Abstract: In summary, tetrandrine can prevent doxorubicin-induced mdr1 mRNA/P-gp expression and P-gp functions in a dose-dependent manner through a mechanism that may involve inhibition of doxorubicin-induced NF-kappaB mRNA expression and protein activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
27
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 14 publications
1
27
0
Order By: Relevance
“…However, inevitable severe side-effects and multiple drug resistance (MDR) limit its application. The mechanism of chemoresistance is complicated and current research involving reversal of MDR is still in the experimental stage (2)(3)(4). It is necessary to develop novel methods to enhance chemosensitivity and to reverse the MDR.…”
Section: Introductionmentioning
confidence: 99%
“…However, inevitable severe side-effects and multiple drug resistance (MDR) limit its application. The mechanism of chemoresistance is complicated and current research involving reversal of MDR is still in the experimental stage (2)(3)(4). It is necessary to develop novel methods to enhance chemosensitivity and to reverse the MDR.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, one NF-B binding site is proximal in the human MDR1 gene promoter. Thus, a PCR method can be used with human MDR1 gene primers to ascertain whether NF-B-binding DNA contains the human MDR1 gene and to perform further quantitative comparisons (Shen et al, 2010). In our ChIP-Q-PCR assay, an NF-B p65-specific antibody was used to preferentially precipitate DNA fragments containing the NF-B-binding region present in the regulatory sequences of genes from MCF-7/Adr cells, and the MDR1 gene was chosen as our target gene.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore it's a promising strategy to "prevent" drug-resistance in cancer cells prior to the resistance is formed. Recently, some of the above P-gp down-regulators, such as CsA and tetrandrine, have also been proved the ability to prevent the induction of P-gp expression [11,18] , which is caused by the short-term exposure of native cancer cells to ADM. So in the present study, we turned our research strategy from "reversing" to "preventing" drug resistance in native cancer cells prior to the resistance is formed, and introduced a new member in the class of compounds with activities to prevent the induced drug resistance.…”
Section: Discussionmentioning
confidence: 99%
“…However, it's really hard to reverse when drug resistance is formed because the cancer cells 111111111 have already expressed high level of P-gp and accompanied with many up-stream and down-stream activated targets through cell signaling pathways [8,9] . Therefore, it is promising and important to explore the strategy for preventing or blocking the occurrence of acquired MDR ahead of reversing MDR in the present and future studies [10,11] .…”
Section: Introductionmentioning
confidence: 99%